Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

October 2019

The Definitive Pharmaceutical Drug Launch Playbook: Every Critical Mistake, Dissected

1. Why Most Drug Launches Fail Before They Begin Roughly two-thirds of new drug launches miss their first-year sales forecasts, […]

The Definitive Pharmaceutical Drug Launch Playbook: Every Critical Mistake, Dissected Read Post »

Hatch-Waxman at 40: The Patent War Manual That Built a $445B Savings Machine, and a Drug Shortage Crisis

The Drug Price Competition and Patent Term Restoration Act of 1984 was not, in any conventional sense, a health policy

Hatch-Waxman at 40: The Patent War Manual That Built a $445B Savings Machine, and a Drug Shortage Crisis Read Post »

How to Identify Generic Drug Entrants Before FDA Approval: The Complete Pre-Approval Intelligence Playbook

Every year, the U.S. pharmaceutical market transfers hundreds of billions of dollars in revenue from branded monopolies to generic competitors.

How to Identify Generic Drug Entrants Before FDA Approval: The Complete Pre-Approval Intelligence Playbook Read Post »

Make Better Decisions

See Plans & Pricing

Recent Posts

Australia’s Drug Patent Clock: The Complete Guide to How Long Protection Actually Lasts
The Reformulation Playbook: How Pharma Uses 505(b)(2) to Lock In New Patents, Block Generics, and Reset Prices
The Drug Patent Cliff: A Procurement Manager’s Sourcing Playbook
Patent Expiration Data: The Procurement Playbook That Cuts Your Drug Spend by 80%
The Hidden IP Trap in Clinical Research: How Unvetted Software and AI Imperil Sponsor Patents

Popular Posts

China’s Irreplaceable Role in the Global Generic Drug API Supply Chain (2026 Report)
First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants
Maximizing Pharmaceutical Patent Longevity: A Mechanistic and Strategic Guide to IP Term Extension and Lifecycle Fortification
The Russian Pharmaceutical Industry: A Definitive Guide to Strategic Evolution, Geopolitical Realities, and Market Sovereignty
Double Your Specialty Pharmacy Margins the Day Generics Launch
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Branded Generics and Why They’re Profitable
The Reformulation Playbook: How Pharma Uses 505(b)(2) to Lock In New Patents, Block Generics, and Reset Prices
Pharma Licensing Deals: The Complete IP, Valuation, and Deal Structure Playbook
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address